The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.

about

Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Imaging Mass Spectrometry Reveals Crosstalk between the Fallopian Tube and the Ovary that Drives Primary Metastasis of Ovarian Cancer

P2860

Q48124146-A642E370-0398-4175-816C-1105DA45715E Q58564653-5C42CE21-A781-4C5D-AEDE-D3F0D62B9882

P2860

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.

Item

http://www.wikidata.org/entity/Q38635932

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.

@en

type

Item

label

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.

@en

prefLabel

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.

@en

P1476

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.

@en

P2093

Abel Matondo

http://www.w3.org/2001/XMLSchema#string

Chi Hoon Maeng

http://www.w3.org/2001/XMLSchema#string

Insug Kang

http://www.w3.org/2001/XMLSchema#string

Jayoung Kim

http://www.w3.org/2001/XMLSchema#string

Joohun Ha

http://www.w3.org/2001/XMLSchema#string

Ju-Seog Lee

http://www.w3.org/2001/XMLSchema#string

Minh Nam Nguyen

http://www.w3.org/2001/XMLSchema#string

Muhammad Shahid

http://www.w3.org/2001/XMLSchema#string

Ngoc Ngo Yen Nguyen

http://www.w3.org/2001/XMLSchema#string

Salima Akter

http://www.w3.org/2001/XMLSchema#string

P2860

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma

Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer

Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.

Cancer statistics, 2007

Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study.

Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

A prognostic gene expression index in ovarian cancer - validation across different independent data sets.

Analysis of gene expression data using BRB-ArrayTools.

Expression signatures of TP53 mutations in serous ovarian cancers.

P2888

s41598-017-08766-5

P304

9689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-08766-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091313351

http://www.w3.org/2001/XMLSchema#string

P698

28851888

http://www.w3.org/2001/XMLSchema#string

P932

5575202

http://www.w3.org/2001/XMLSchema#string

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.

about

P2860

P2860

The Prognostic 97 Chemoresponse Gene Signature in Ovarian Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932